Kuwait vs Mongolia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Kuwait
2 patients
in 2021
Mongolia
2 patients
in 2021
Kuwait rank
125th
Mongolia rank
125th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Kuwait
- Mongolia
How they compare
Kuwait currently reports 2 patients against 2 patients in Mongolia, a difference of 0 patients.
The two have swapped places 1 time across 19 shared years of data; in 2003 it was Kuwait ahead.
Kuwait ranks 125th and Mongolia ranks 125th of 183 countries.
Across the 3 decades both report, Kuwait averaged higher in 1 and Mongolia in 1.
Head to head by decade
| Decade | Kuwait | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.71 patients | 0.5714 patients | 2.14 patients | Kuwait |
| 2010s | 1.8 patients | 3.8 patients | 2 patients | Mongolia |
| 2020s | 3 patients | 3 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Kuwait or Mongolia?
- Kuwait, at 2 patients against 2 patients in Mongolia as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Kuwait and Mongolia?
- 0 patients, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and Mongolia?
- 19 years are reported by both, from 2003 to 2021.
- How do Kuwait and Mongolia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Kuwait ranks 125th and Mongolia ranks 125th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.